Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Viral uveitis in the tropics].

Journal francais d'ophtalmologie·2024
Same author

[Anatomical and functional outcomes of the "3+PRN" therapeutic protocol in the treatment of diabetic macular edema].

Journal francais d'ophtalmologie·2024
Same author

Successful management of dry eye disease with a new eye drop formulation combining hyaluronic acid, trehalose, and N-acetyl-aspartyl-glutamic acid (NAAGA).

Journal francais d'ophtalmologie·2024
Same author

[Chorioretinal involvement in West Nile virus infection].

Journal francais d'ophtalmologie·2023
Same author

[Role of optical coherence tomography in unilateral amblyopia].

Journal francais d'ophtalmologie·2023
Same author

Ocular tuberculosis presenting with a conjunctival granuloma.

Journal francais d'ophtalmologie·2023

Related Experiment Video

Updated: May 17, 2026

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
09:42

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

[The eye and Behçet's disease].

M Khairallah1, S Ben Yahia, R Kahloun

  • 1Service d'ophtalmologie, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, Monastir, Tunisie. moncef.khairallah@rns.tn

Journal Francais D'Ophtalmologie
|October 23, 2012
PubMed
Summary
This summary is machine-generated.

Behçet's disease (BD) is a systemic vasculitis causing oral and genital ulcers, skin lesions, and uveitis. Current treatments like azathioprine and corticosteroids improve visual prognosis, with biologics offering advanced options for severe cases.

More Related Videos

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

Related Experiment Videos

Last Updated: May 17, 2026

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
09:42

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

Area of Science:

  • Systemic inflammatory disorders
  • Vascular inflammation
  • Autoimmune diseases

Context:

  • Behçet's disease (BD) is a multisystem inflammatory disorder characterized by occlusive vasculitis, prevalent in Mediterranean, Middle Eastern, and Far Eastern populations.
  • Key clinical features include recurrent oral and genital ulcerations, ocular inflammation (uveitis), skin lesions, and systemic manifestations.
  • The etiology of BD remains incompletely understood, with proposed contributions from infectious, genetic (HLA-B51), and environmental factors.

Purpose:

  • To review the clinical characteristics, pathogenesis, and management of Behçet's disease, with a focus on ocular involvement (uveitis).
  • To highlight the diagnostic importance of uveitis in BD and its potential for severe visual impairment.
  • To discuss current therapeutic strategies and future directions for managing BD and its ocular complications.

Summary:

  • Behçet's disease is a systemic inflammatory condition with vasculitis as its hallmark pathology.
  • Uveitis is the most frequent ocular manifestation, significantly impacting visual prognosis and serving as a key diagnostic criterion.
  • Management involves a multidisciplinary approach, with immunosuppressants (azathioprine, corticosteroids) and biologics (cyclosporine A, infliximab, IFNα) guiding treatment based on disease severity.

Impact:

  • Improved understanding of Behçet's disease pathogenesis and clinical management, particularly for uveitis.
  • Enhanced visual outcomes for patients with Behçet's uveitis due to optimized treatment strategies.
  • Foundation for developing novel, targeted therapies for autoimmune diseases and inflammatory conditions.